EXO-CD24
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EXO-CD24, covering 2023-07-27 to 2023-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS [Phase 2]